Mindfulness tailored for trauma: a new approach to chronic pain after abuse

NCT ID NCT07700355

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study develops and tests a program called MBCT-TIP, which combines mindfulness-based cognitive therapy with trauma-informed care for adults who have chronic pain and a history of intimate partner violence. Participants attend eight weekly group sessions and complete assessments before, after, and three months later. The goal is to see if the program is practical and acceptable for this group, and whether it helps reduce pain interference and post-traumatic stress symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a behavioral program called Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP)
What this could lead to
If successful, this program could offer a new, trauma-informed way to help people with chronic pain and a history of intimate partner violence manage their pain and improve daily functioning.
What could go wrong
This is a small, early-stage feasibility study, so results may not apply broadly. The program may not prove more effective than the control group, and participation requires attending weekly group sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2027

An estimate. Start dates often move.

Expected to finish

Aug 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 or older * Primary care patient at Fish Center or other Mass General Brigham (MGB) primary care clinic * Diagnosis of chronic primary pain (≥3 months), per ICD-11 criteria * Pain severity of ≥4 on the Numeric Pain Rating Scale (NRS) * History of intimate partner violence (IPV), e.g., via the Abuse Assessment Screen (AAS) Exclusion Criteria: * Significant change in psychiatric medication or therapy in the past 3 months * Untreated or poorly controlled severe mental health disorder(s) * Active or high suicide risk in the past 90 days (via PHQ-9 item #9 or otherwise reported, with subsequent risk assessment as needed) * Untreated or poorly controlled PTSD, as assessed by the Primary Care PTSD Screen or clinically by the primary care provider (PCP) or consulting psychiatrist * Untreated or poorly controlled substance use disorder that, per patient self-report or the primary care team, would interfere with the ability to participate * Moderate-to-severe cognitive impairment or inability to provide informed consent * Inability to consistently participate in sessions * Lack of verbal and written English fluency * Otherwise deemed by referring PCP to be inappropriate for inclusion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Brigham and Women's Fish Center for Women's Health

    Boston, Massachusetts, 02467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.